Krolik M, Csepregi L, Hartmann F, Engetschwiler C, et al. Recombinant lymphocytic choriomeningitis virus-based vaccine vector protects type
I interferon receptor deficient mice from viral challenge. Vaccine 2021 Jan 28. pii: S0264-410X(21)00074.
PMID: 33518468